Blood, Vol. 94 No. 8 (October 15), 1999:
pp. 2790-2799
Analysis of T Cells in Paroxysmal Nocturnal Hemoglobinuria Provides
Direct Evidence That Thymic T-Cell Production Declines With Age
By
Stephen J. Richards,
Gareth J. Morgan, and
Peter Hillmen
From the Haematological Malignancy Diagnostic Service, Leeds General
Infirmary, Leeds, UK.
 |
ABSTRACT |
Peripheral blood T cells in patients with paroxysmal nocturnal
hemoglobinuria (PNH) comprise a mixture of residual normal and
glycosylphosphatidylinositol (GPI)-deficient PNH cells. Using multicolor flow cytometry, we demonstrated significant differences between the proportions of naive and memory cells within these populations. PNH T cells comprise mainly naive cells
(CD45RA+CD45R0
), whereas normal T cells in
the same patients were predominantly memory
(CD45RACD45R0+) cells. Functional analyses
showed that GPI-deficient CD45RA+ T cells can convert to
a CD45R0+ phenotype. We present data from a PNH patient
in remission for 20 years who still had significant numbers of
GPI-deficient T cells; these showed a normal distribution of naive and
memory components. The predominantly naive phenotype of GPI-deficient T
cells seen in PNH patients with active disease likely reflects the
phenotype of recent normal thymic emigrants. In patients where hematopoiesis was predominantly derived from the PNH stem cell, absolute numbers of both naive PNH CD4+ cells and
CD8+ cells show an inverse correlation with patient age,
implying this age-related decline in T-cell production is secondary to a decrease in thymic activity rather than a stem cell defect.
© 1999 by The American Society of Hematology.
| |
INTRODUCTION |
PAROXYSMAL NOCTURNAL hemoglobinuria (PNH)
is an acquired pluripotent hematopoietic stem cell (HSC) disorder in
which a somatic mutation of the X-linked PIG-A gene results in
a partial or absolute deficiency of all proteins linked to the cell
membrane by a glycosylphosphatidylinositol (GPI) anchor.1-6
PNH is closely associated with bone marrow failure syndromes and many
patients have severe bone marrow aplasia, pancytopenia, and little
residual normal hematopoiesis.7,8 After onset of the
disease and failure of normal hematopoiesis, the vast majority of new
blood cell formation in PNH patients is clonally derived from the PNH
stem cell. Although the major emphasis of published work has been on
abnormalities of erythroid and myeloid cells, we and others have shown
that GPI-deficient lymphocyte populations are present in a high
proportion of patients with PNH.9-11 Peripheral blood T
cells in most PNH patients comprise an admixture of residual normal T
cells and T cells belonging to the PNH clone. These studies not only
confirm that PNH is a true pluripotent HSC disorder, but also open up the possibility of using GPI deficiency as a surrogate biological marker to study T lymphopoiesis. PNH lymphocytes can be identified by
lack of expression of GPI-anchored proteins such as CD48, CD52, CD58,
or CD59. What effect, if any, this deficiency has on lymphocyte function in vivo or in vitro has not been extensively investigated, although previous studies have described regulatory roles for CD48 and
CD59 in T-cell activation and an in vitro growth advantage for PNH T
cells compared with normal T cells.10,12-15 In vivo activation of normal T cells by foreign antigen induces upregulation in
expression of class II major histocompatability complex (MHC) antigens
(HLA-DR) and cytokine receptors such as CD25. If the stimulus is from a
previously unencountered antigen, then memory T-cell formation occurs
as an integral part of the immune response. The acquisition of T-cell
memory is associated with a switch in CD45R isoform expression from a
CD45RA+R0 naive phenotype to
CD45RAR0+ primed or memory cell
phenotype.16-19 As this is a dynamic process and occurs
throughout the life span of an individual, there are always detectable
HLA-DR+ T cells and long-lived memory (CD45R0+)
T cells in adult peripheral blood.
In this present study, we examined in detail the differential
expression of CD45R and HLA-DR determinants by normal and GPI-deficient T-cell populations in patients with PNH. In addition, the absence of
GPI-linked antigens from PNH T cells provided a novel marker with which
to examine the contribution of thymic-dependant and independent
pathways to the maintenance of T-cell numbers and the relationship to
patient age.
| |
MATERIALS AND METHODS |
Patients studied.
Peripheral blood samples from a series of 28 adult patients with PNH
and 1 patient known to have had a spontaneous remission of PNH 20 years
previously, were screened for the presence of GPI-deficient T-cell
clones using established protocols.9 Informed consent was
obtained from individual patients before specimen collection. The
initial diagnosis of PNH was made by demonstrating the absence of
GPI-linked proteins from red blood cell and/or granulocyte
cell membrane by flow cytometry or by a positive Ham test.20,21 PNH T-cell clones were detected in 22 of 29 cases. The patient group comprised 9 males and 13 females with an age range of 23 to 74 years. Further analyses of these 22 patients undertaken for the purposes of this study included determination of the
absolute numbers of T cells and T-cell subsets by flow cytometry as
detailed below. Full blood counts including absolute numbers of
lymphocytes were performed using a Sysmex K1000 cell counter (Sysmex,
Milton Keynes, UK). In vitro functional studies were performed on 2 patients.
Separation of mononuclear cells.
Mononuclear cells were fractionated from 10 mL volumes of EDTA
anticoagulated peripheral blood by conventional density sedimentation with Lymphoprep (Nycomed, Oslo, Norway). Cells collected from the
plasma/lymphoprep interface were washed twice with 10 mL volumes of
FACSFlow (Becton Dickinson, San Jose, CA) supplemented with 0.5%
bovine serum albumin (FACSFlow/BSA; Sigma Chemicals, St Louis, MO) and
the white blood cell count adjusted to 50 × 109/L for
subsequent immunophenotyping studies.
Lymphocyte subsets.
An initial whole blood lysis screen was performed to assess the
proportions and absolute numbers of T cells and T-cell subsets. Briefly, 30 µL volume of a prestandardized combination of CD4/CD8/CD3 monoclonal antibodies (fluorescein isothiocyanate
[FITC]/phycoerythrin [PE]/PE:Cy5) was pipetted into a
12 × 75 mm polystyrene tube (Becton Dickinson). One hundred
microliters of EDTA anticoagulated whole blood was then added, mixed,
and incubated in the dark at ambient temperature for 20 minutes,
punctuated by gentle mixing every 5 minutes. A 2-mL volume of a 1/10
dilution of fluorescence-activated cell sorting (FACS)
lysing solution (Becton Dickinson) was added to the tube, gently mixed,
and incubated for a further 10 minutes in the dark. The tubes were then
centrifuged at 300g for 90 seconds, the supernatant discarded,
and the white blood cell pellet resuspended in a 2-mL volume of
FACSFlow/BSA. The cells were again pelleted and washed with a further 2 mL volume of FACSFlow/BSA. After this final wash stage, the cells were
resuspended in a 300-µL volume of a 1/10 dilution of CellFIX (Becton
Dickinson) and incubated for a minimum of 5 minutes before flow
cytometry analysis. The cells were then analyzed using a FACScan flow
cytometer (Becton Dickinson) and Lysis II software (Becton Dickinson)
collecting a minimum of 1 × 104 gated lymphocyte
events identified by low forward scatter (FSC) and low side scatter
(SSC) characteristics. Absolute numbers of T cells, T-helper, and
T-cytotoxic cells were calculated using the Sysmex lymphocyte count
multiplied by the percentage of lymphocytes expressing CD3,
CD3+CD4+, and CD3+CD8+
determinants divided by 100, respectively. Additional analyses of CD4
versus CD8 dot plots for CD3 gated lymphocytes showed that the
percentage of dual positive (CD4+CD8+) was less
than 1% in all cases.
Immunophenotyping and flow cytometry of lymphocytes by whole blood
lysis.
A total of 100-µL volumes of whole blood were stained as described
above with 30-µL volumes of the following combinations of monoclonal
antibodies (FITC/PE/PE:Cy5): CD48/CD45RA/CD3, HLA-DR/CD48/CD3; CD48/CD45RA/CD4, CD48/CD45RA/CD8. The cells were analyzed by flow cytometry using a FACScan flow cytometer with Lysis II software. A
minimum of 5 × 103 gated events were collected on
specific lymphocyte populations identified by low side scatter
characteristics and either CD3, CD4, or CD8 positivity (summarized in
Fig 1). Data was stored as list mode files
for subsequent analysis. Quadrant statistical analyses of dot plots of
CD48 versus either CD45RA or HLA-DR were undertaken, and the
proportions of normal and PNH lymphocytes expressing CD45RA or HLA-DR
calculated. Absolute numbers of GPI-deficient naive T helper and
T-cytotoxic lymphocytes were calculated by mutiplying the absolute
numbers of CD4+ or CD8+ lymphocytes by the
percentage of
CD48CD45RA+R0 cells
within each fraction, divided by 100.
View larger version (29K):
[in this window]
[in a new window]
| Fig 1.
Flow cytometry gating procedures. Representative dot plot
examples of (A) side scatter (SSC) versus CD3, (B) SSC versus CD4, and
(C) SSC versus CD8 used for identification of T cells, T-helper cells,
and T cytotoxic cells, respectively. Specimens were prepared by whole
blood lysis as detailed in Materials and Methods. The individual gating
regions (R1, R2, and R3) denote the live gates used for data
acquisition.
|
|
Immunophenotyping and flow cytometry of mononuclear cells.
A total of 10 µL volumes of mononuclear cells were stained in
U-shaped microtiter plate wells with the following three-color combinations of monoclonal antibodies (FITC/PE/PE:Cy5):
CD59/CD45R0/CD4, and CD59/CD45R0/CD8. The cell/antibody combinations
were mixed, incubated at room temperature for 30 minutes, and then
centrifuged at 400g for 15 seconds to pellet the cells. After
removal of excess antibody and washing twice with 150 µL volumes of
FACSFlow/BSA, the cells were resuspended to 300 µL in FACSFlow before
flow cytometry studies. Cells were then analyzed by flow cytometry
using a FACScan flow cytometer with Lysis II software. A minimum of 2 × 104 gated lymphocytes were collected on the basis
of low side scatter characteristics and either CD4 or CD8 positivity.
The proportions of normal and PNH lymphocytes expressing CD45R0 were
derived from quadrant statistical analysis of CD59 versus CD45R0 dot plots.
Functional studies/cell culture anti-CD3 solid phase stimulation of
T cells.
To examine the ability of both normal and PNH T cells to convert from a
CD45RA+ phenotype to a CD45R0+ phenotype,
peripheral blood lymphocytes were stimulated in vitro with anti-CD3
using a method described by Frolova et al.22 Briefly, 20-mL
volumes of peripheral blood were collected from 2 patients with PNH
(PNH 042 and 043) into sterile sodium heparin anticoagulant (Becton
Dickinson Vacutainer Systems, Rutherford, NJ). Mononuclear cells were
isolated under sterile conditions using density gradient sedimentation
as described above. The mononuclear cells were washed twice with 10-mL
volumes of sterile RPMI-1640 media (GIBCO, Paisley, UK) containing 5%
fetal calf serum (GIBCO), penicillin (100 U/mL), and streptomycin (100 µg/mL). The final cell count was adjusted to 1 × 109/L for cell culture studies. Anti-CD3 solid phase 50-mL
cell culture flasks (Nalge Nunc International, Roskilde,
Denmark) were prepared in advance by coating with 10-mL volumes of anti
CD3 (OKT3-American Type Culture Collection [ATCC]) at a concentration
of 10 µg/mL and incubated overnight at 4°C. The flasks were then
washed 5 times with 10-mL volumes of sterile phosphate-buffered saline (pH 7.2). Mononuclear cells were cultured in a humidified 5%
CO2 atmosphere at 37°C. After 5 days in culture, cells
were harvested and stained with the following combinations of
monoclonal antibodies for flow cytometry CD45R0/CD48/CD4 and
CD45R0/CD48/CD8 as described above. A minimum of 1 × 104 gated lymphocytes were collected on the basis of side
scatter characteristics and either CD4 or CD8 positivity. The
proportions of normal and PNH lymphocytes expressing CD45R0 were
derived from quadrant statistical analysis of CD48 versus CD45R0 dot
plots and compared with the values obtained for cells before stimulation.
Monoclonal antibodies.
The sources and specificities of all monoclonal antibodies used for
immunophenotyping were as follows: CD3 (OKT3 FITC, PE and PE:Cy5), CD8
(OKT8 FITC, PE and PE:Cy5), and HLA-DR (L243 FITC and PE) from American
Type Culture Collection (ATCC), Rockville, MD; CD4 (QS4120
FITC, PE and PE/Cy5) and CD45R0 (UCHL1 FITC and PE) from University
College and Middlesex School of Medicine, London, UK; CD45RA (2H4 PE)
Coulter-Immunotech, Luton Bedfordshire, UK; CD48 (MEM102 FITC and PE)
and CD59 (MEM43 FITC) from Cymbus Biotechnology Limited, Chandler's
Ford, Hampshire, UK.
| |
RESULTS |
The clinical, hematological, and laboratory features of the 22 patients
examined in the study are summarized in
Table 1. Nine patients had hypoplastic PNH,
11 hemolytic PNH, and a single patient, who originally presented with
hemolytic PNH, was nonhemolytic with only 0.5% GPI negative red blood
cells and a normal hemoglobin. GPI-deficient red blood cells and
neutrophils were found in all cases, except patient PNH 030, who had a
spontaneous remission 20 years previously. The median size of the PNH
granulocyte clone was 91.6%, this was taken as a reliable indicator
that the majority of hematopoiesis was clonally derived from the PNH
stem cell. With the exception of 1 patient (detailed below), no one was
currently receiving immunosuppressive therapy. Patient PNH007 was given a single course of cyclosporin A in 1990 and PNH012 was unresponsive to
a single course of antilymphocyte globulin given in 1988. Patient PNH043 is currently receiving cyclosporin A.
PNH T-cell clones.
Of the 21 patients studied with active disease, the median proportion
of PNH T cells was 8.7% (range, 0.2% to 30.4%). One case (PNH063)
showed a population of partially GPI-deficient T cells comprising 8.1%
of total.
HLA-DR expression by CD48+ and CD48
subpopulations of T cells.
To study the expression of HLA-DR by PNH (CD48) T
cells compared with the same patient's residual normal
(CD48+) T cells, three-color flow cytometry studies were
performed on 13 patients with previously identified PNH T-cell clones.
Results from these studies (Table 2) showed
absent or reduced levels of HLA-DR expression within the PNH component
when compared with patient constituent normal T cells. These
differences in HLA-DR expression were statistically significant (paired
t-test: t = 5.64; degrees of freedom
[df], 12; P < .001). Representative two-color dot plots of CD48 versus HLA-DR for CD3 gated lymphocytes
(Fig 2A and B) clearly illustrate the
differences in HLA-DR expression by PNH T cells compared with
constituent normal T cells. Furthermore, in 7 of 13 (54%) cases
analyzed, the normal T-cell component comprised a significantly higher
proportion of HLA-DR expressing cells than would be expected for normal
healthy controls suggesting an ongoing immune response. Interestingly,
the patient with partially GPI-deficient T cells showed similar results
to the patients with a total GPI deficiency (Fig 2C).
View this table:
[in this window]
[in a new window]
|
Table 2.
Comparative Expression of CD45RA and HLADR by
CD48+ (Normal) and CD48 (GPI-Deficient)
Subpopulations of T Cells in Patients With PNH
|
|
View larger version (49K):
[in this window]
[in a new window]
| Fig 2.
Analysis of HLA-DR and CD45RA expression on normal
(CD48+) and PNH (CD48) components of
peripheral blood T cells by three-color flow cytometry. Initial gating
of T cells was based on low SSC characteristics and CD3 positivity as
described in Materials and Methods and in Fig 1. The upper two-color
dot plots (A through C) show the difference in HLA-DR expression
between CD48+ and CD48 T cells in 3 representative patients with PNH. The percentage of normal and PNH T
cells expressing HLA-DR are shown in the upper and lower quadrants,
respectively. Not only is HLA-DR expression absent on GPI negative T
cells (plots A and B), but also on T cells with partial GPI deficiency
(plot C). The lower dot plots (D through F) show the differences in
CD45RA expression by normal (CD48+) and PNH
(CD48) T cells. The proportion of naive T cells is much
higher within the GPI-deficient compartment, independent of whether
there is complete (plots D and E) or partial deficiency (plot F) of
GPI-anchored proteins. The normal T-cell components have a
predominantly memory (CD45RA) phenotype.
|
|
To determine whether increased HLA-DR expression by T cells was
associated with hemolytic or aplastic forms of the disease, statistical
analysis of the data was undertaken. No significant relationship was
found (Mann-Whitney; z = 
1.10; P = .2701). The possibility that the percentage of T cells that were
HLA-DR+ may inversely correlate with CD4 count as a
reflection of peripheral expansion as a result of T-cell depletion was
also examined. No correlations were found (Spearman's (rs)
0.125; P = .577).
CD45RA expression by CD48+ and CD48
subpopulations of T cells.
To compare the expression of CD45RA by PNH T cells with patients'
residual normal T cells, three-color flow cytometry studies were
performed on 15 patients with PNH T-cell clones. Results from these
studies (Table 2) showed a much higher proportion of
CD45RA+ (naive) T cells within the PNH component when
compared with the residual normal T cells. These differences were
highly statistically significant (paired t test: t = 15.42; df 14; P < .001). Typical two-color dot plots of CD48
versus CD45RA for CD3 gated lymphocytes (Fig 2D through F)
clearly illustrate the differences in CD45RA expression by completely
and partially deficient PNH T cells compared with residual normal T cells.
CD45RA expression by CD48+ and CD48
subpopulations of CD4+ and CD8+ T-cell subsets.
Having shown clear differences in CD45RA expression between normal and
PNH T cells, the analysis was extended to examine expression of CD45RA
by normal and PNH components of CD4+ and CD8+
lymphocyte subsets. CD4+ lymphocytes from 18 patients with
PNH T-cell clones were studied by three-color flow cytometry and by
setting appropriate CD4/SSC gates (Fig 1B), the proportions of
CD45RA+ components within CD48+ and
CD48 populations were analyzed on two-color dot
plots. Results (Table 3 and
Fig 3) clearly showed that
CD4+CD48 lymphocytes were predominantly
CD45RA+CD45R0 and that
CD4+CD48+ lymphocytes showed either normal or
reduced proportions of CD45RA+ components. These
differences were statistically significant (paired t test:
t = 18.35; df = 17; P < .0001). Similar
differences were demonstrated between PNH and normal components of the
CD8+ lymphocyte subset (paired t test: t = 8.11; df 17; P < .0001). The PNH component of
CD8+ lymphocytes showed a predominantly naive
(CD45RA+) phenotype (Table 3 and Fig 3). The
CD48+ components showed normal distributions of
CD4+CD45RA+ in 11 of 19 cases, increased
proportions of CD4+CD45RA cells in 6 of
19 cases, and reduced proportions in 2 of 19. For CD8+CD48+ lymphocytes, normal CD45RA expression
was present in 8 of 21 cases, increased proportions of
CD45RA lymphocytes present in 8 of 21, and decreased
proportions of CD45RA lymphocytes in 5 cases. In the
patient who had undergone spontaneous remission of PNH (case PNH030),
the distribution of naive and memory components within both the normal
and PNH components of both CD4+ and CD8+
lymphocyte subsets were normal.
View this table:
[in this window]
[in a new window]
|
Table 3.
Comparative Expression of CD45RA by CD48+
(Normal) and CD48 (GPI-Deficient) Components of
CD4+ and CD8+ T-Cell Subpopulations in
Patients With PNH
|
|
View larger version (45K):
[in this window]
[in a new window]
| Fig 3.
Representative dot plots comparing CD45RA and CD45R0
expression by normal (CD48+) and PNH
(CD48) lymphocytes for CD4+ (T-helper) and
CD8+ (T-cytotoxic) populations. Plots A and B show that
the proportion of CD45RA+ cells is significantly higher
(75% and 94%, respectively) for PNH components of the
CD4+ and CD8+ subpopulations when compared
with the residual normal components (28% and 57%, respectively),
which are predominantly CD45RA. Plots C and D are
representative examples comparing CD45R0 expression by normal
(CD59+) and PNH (CD59) lymphocytes for
CD4+ (T-helper) and CD8+ (T-cytotoxic)
populations. As expected, the proportion of CD45R0+ cells
is significantly lower (16% and 2%, respectively) for PNH components
of the CD4+ and CD8+ subpopulations when
compared with the normal components (44% and 57%, respectively).
Plots E and F show the proportions of CD45RA+ components
within the normal and PNH fractions of the CD4+ and
CD8+ lymphocyte subsets of patient PNH030, who had a
spontaneous remission of PNH 20 years ago. The plots show normal
distributions of naive (CD45RA+) and memory cells
(CD45RA) for all populations.
|
|
CD45R0 expression by CD59+ and CD59
subpopulations of CD4+ and CD8+ T-cell subsets.
Having shown clear differences in CD45RA expression between normal and
PNH T cells, expression of CD45R0 by normal and PNH constituents of
CD4+ and CD8+ lymphocyte subsets was studied in
11 patients using CD59 as the GPI-linked marker. As CD59 is
ubiquitously expressed by hematopoietic cells and is therefore
unsuitable for use in a whole blood lysis technique, the analysis was
performed on separated mononuclear cell fractions. CD45R0 antigen is
reciprocally expressed in relation to CD45RA.23,24 Analysis
of two-color dot plots of CD45R0 versus CD59 for CD4+ and
CD8+ lymphocyte subsets as expected showed PNH lymphocyte
components to be predominantly CD45R0
(Table 4 and Fig 3). Statistically
significant differences in expression of CD45R0 were demonstrated
between PNH and normal components for both CD4+ and
CD8+ lymphocyte subsets (paired t-test: t = 12.5; df 10; P < .0001 and t = 6.60; df 10; P < .0001, respectively).
View this table:
[in this window]
[in a new window]
|
Table 4.
Comparative Expression of CD45R0 by CD59+
(Normal) and CD59 (GPI-Deficient) Components of
CD4+ and CD8+ T-Cell Subpopulations in
Patients With PNH
|
|
Functional studies.
As the majority of GPI-deficient T cells in PNH patients have a naive
(CD45RA+R0) phenotype, we performed in
vitro functional studies on 2 patients to determine whether these cells
were capable of converting to a memory cell phenotype upon activation.
After 5 days in culture using an anti-CD3 solid phase to stimulate T
cells, residual normal and GPI-deficient populations for both
CD4+ (T-helper) and CD8+ (T-cytotoxic)
subpopulations showed complete conversion to a memory cell phenotype
(CD45R0+) (Fig 4). These
results clearly show that absence of GPI-anchored proteins from the
membrane of PNH T cells does not prevent conversion to a memory cell
phenotype after activation.
View larger version (39K):
[in this window]
[in a new window]
| Fig 4.
Flow cytometry dot plots from 2 patients (PNH042 and PNH
043) showing conversion of GPI-deficient T cells from a naive phenotype
(CD45R0) to a memory (CD45R0+) phenotype
after stimulation in an anti-CD3 solid phase culture system. Plots A
and C and E and G are unstimulated CD4+ lymphocytes and
CD8+ lymphocytes, respectively. These plots clearly
illustrate that the GPI-deficient (CD48) components to
be predominantly CD45R0. After stimulation, these
GPI-deficient populations convert to a memory cell phenotype with
greater than 96% coexpression of CD45R0+ for
CD4+ (plots B and D) and CD8+ (plots F and
H) subsets in both cases studied. The residual normal components
(CD48+) of CD4+ and CD8+
lymphocytes although showing variable proportions of memory cells in
the unstimulated controls (plots A, C, E, and G), also show maximal
conversion (greater than 99%) to a memory cell phenotype in all
instances (plots B, D, F, and H).
|
|
Relationship between age and absolute numbers of naive
(CD45RA+) PNH T cells.
PNH T cells, which have a naive
(CD45RA+CD45RO) phenotype consistent
with having undergone thymic differentiation,25 are unequivocally produced from bone marrow-derived hematopoietic progenitor cells. Therefore, in patients where the majority of hematopoiesis is derived from the PNH stem cell (ie, granulocytes predominanly GPI-deficient), the relationship between patient age and
absolute numbers of these cells was examined as a potential indicator
of naive T-cell production. Statistically significant inverse
correlations (Fig 5) were found between
patient age and absolute numbers of both naive PNH CD4 and PNH CD8
lymphocyte subpopulations (Spearman's (rs) 0.719;
P = .003) and (rs 0.545; P = .036) respectively.
View larger version (18K):
[in this window]
[in a new window]
| Fig 5.
Relationship between patient age and absolute numbers of
CD45RA+, GPI-deficient T-cell subsets in patients with
PNH. Both CD4+ T cells (plot A) and CD8+ T
cells (plot B) show an inverse relationship between increasing age and
decreasing absolute numbers of naive T cells. Correlations determined
by Spearman rank order (rs).
|
|
| |
DISCUSSION |
Peripheral blood T cells in a high proportion of patients with PNH
comprise a variable mixture of normal cells and T cells belonging to
the PNH clone.9-11 Using multicolor flow cytometry, these 2 populations can be clearly resolved by demonstrating the presence or
absence of GPI-anchored proteins from the cell surface. By studying the
phenotypic characteristics of these 2 populations, we have been able to
resolve some of the current contentions regarding T cell lymphopoiesis,
particularly the relative contributions of thymic-dependent and thymic
independent pathways to the maintenance of peripheral blood T-cell
numbers in adults.26
The essential role of the thymus in primary T lymphopoiesis and
development of a diverse antigen receptor repertoire is an established
tenet of contemporary immunology.27 Thymic-dependent generation of naive T cells occurs primarily in neonates and children, although the specific contribution of thymopoiesis to the maintenance of T-cell numbers and antigen repertoire diversity in adults is largely unknown.25,28,29 Mature, naive T cells that emerge from the thymus have a well characterized immunophenotype of
CD3+CD45RA+CD45R0CD1CD27+
with concomitant expression of either CD4 (MHC Class II) or CD8 (MHC class I) ligands.25,28,30,31 Important insights into adult T-cell lymphopoiesis were provided by the work of Mackall et
al,32 who showed that the capacity to produce naive T cells after intensive chemotherapy was inversely related to patient age. In
addition, they and others demonstrated that even in young adults with
residual thymic function, initial recovery of T-cell numbers
postchemotherapy is primarily by peripheral expansion of existing
T-cell populations.32,33 This short-term T-cell regeneration is predominantly antigen driven and accompanied by a
skewing in antigen receptor diversity and a subset imbalance that may
persist for a considerable period of time.34,35
The exact contribution of thymopoiesis to long-term restoration of
T-cell numbers remains poorly characterized and certainly in patients
who have undergone chemotherapy or bone marrow transplantation, it is
not possible to definitively separate T cells produced by peripheral
expansion of existing mature T-cell populations from those derived de
novo from HSC. Conventional studies have relied upon detecting
differential expression of CD45 isoforms by flow cytomtery to identify
naive (CD45RA+R0) and memory
(CD45RAR0+) T
cells.17-19,23-32 However, more recent publications have
shown that these markers alone are not an entirely a reliable
discriminator of naive and memory cell status, particularly for
CD8+ T cells.36-38 A clearer understanding of
the relative contributions of the distinct pathways of T-cell
production is highly desirable for 2 main reasons. First, peripheral
expansion of existing T-cell populations results in a concomitant
contraction in T-cell antigenic repertoire.34 Second, a
long-term failure to produce sufficient numbers of new naive T cells
has obvious implications for cell-mediated immunity and mounting an
effective immune response to new pathogens.
Using multicolor flow cytometry, we compared the immunophenotypic
characteristics of normal and GPI-deficient populations of T cells in
PNH patients with respect to activation antigen expression (HLA-DR) and
the high and low molecular weight isoforms of the common leukocyte
antigen, CD45RA and CD45R0. Preliminary studies showed significantly
lower levels of HLA-DR expression on PNH T cells when compared with
coexisting normal T cells. Furthermore, differences were found between
the distributions of naive and memory cells within normal and PNH
T-cell clones. PNH T cells comprised mainly naive T cells, whereas
normal T cells showed either normal or increased proportions of memory
cells. When this analysis was extended to CD4+ (T-helper)
and CD8+ (T-cytotoxic) lymphocyte subpopulations, similar
significant differences in CD45RA expression were found, with the PNH
clones having a predominantly naive phenotype. Interestingly, residual normal CD4+ lymphocytes in one third of patients showed a
marked increase in the proportion of cells with a memory cell
phenotype, consistent with having undergone peripheral expansion.
However, this contention was not supported by statistical analysis of
the correlation between HLA-DR expression by T cells and
CD4+ count. An inverse correlation was not found as might
be expected if the increased proportions of memory cells were the
result of peripheral expansion due to T-cell depletion.
As PNH T cells are unequivocally derived from a multipotent HSC with a
somatic mutation of the PIG-A gene and have a naive (CD45RA+CD45R0HLADR)
phenotype consistent with having undergone thymic differentiation, we
examined the relationship between patient age and absolute numbers of
these cells as a potential indicator of naive T-cell production. In
those patients where hematopoiesis was predominantly maintained by the
PNH HSC (ie, a predominant GPI-deficient granulocyte clone),
statistical analysis of the relationship between patient age and
absolute numbers of either naive PNH CD4 or PNH CD8 lymphocytes conclusively showed inverse correlations for both subsets (Spearman's (rs) 0.709; P = .0045) and (rs 0.572; P = .033) respectively. The data strongly
support the idea that the ability to produce thymic-derived naive T
cells and therefore maintain antigen receptor diversity falls
dramatically with age. The fact that the PNH stem cell produces
GPI-deficient neutrophils, red blood cells, and monocytes in relatively
normal numbers suggests that this age-related decline in T-cell
production is secondary to a decrease in thymic activity rather than a
stem cell defect. This contention is further supported by data from
patient 027, diagnosed as PNH 7 years previously, who at the age of 74 years had predominantly PNH hematopoiesis (ie, greater than 95%
granulocyte clone) with virtually no detectable PNH T cells. Normal
lymphopoietic activity in this patient is inferred by the finding that
natural killer (NK) cells, known to be derived from a common lymphoid
progenitor, were predominantly GPI-deficient.28,39
The interpretations of the data we present make the tacit assumption
that absence of GPI antigens from PNH T cells has no detrimental effect
on development or function. This supposition is supported by in vitro
functional studies on 2 patients, which clearly showed that
GPI-deficient CD4+ and CD8+ T cells that were
predominantly CD45R0, underwent activation and
converted to a CD45R0+ phenotype. Further evidence to
support normal function comes from murine studies that show (1)
embryonic stem cells with a nonfunctional pig-a gene are competent for
hematopoiesis and (2) a CD48 knockout mouse has only minor
abnormalities in T-lymphocyte functional activity.40,41
Therefore, it is highly likely that the predominantly naive phenotype
of PNH T cells we describe is a reflection of recent production rather
than an intrinsic inability to activate due to GPI deficiency. The
predominantly naive phenotype of PNH T cells is because the process of
T-cell activation and memory cell formation may take a number of years
to occur, reflecting the picture seen in normal healthy
infants.42 This contention is supported by studies of 1 patient (PNH030) who underwent spontaneous remission of PNH 20 years
ago who still has significant numbers of PNH T cells and B cells. This
patient's GPI-deficient T-cell subsets show normal distributions of
naive and memory cell components. Further studies involving serial
monitoring at yearly intervals of memory T-cell formation in the
individual patients reported in this study are currently in progress.
These studies provide important new insights into adult T
lymphopoiesis, specifically that the ability to produce naive T cells
through thymic dependent pathways declines to very low levels around
the age of 40. Furthermore, the findings show that after failure of
normal hematopoiesis in patients with PNH, peripheral expansion is the
primary mechanism by which normal peripheral T-cell numbers are
maintained. The increasing use of bone marrow transplantation and novel
therapies such as monoclonal antibodies for treating a range of
malignant and autoimmune diseases invariably results in a profound
T-cell depletion.42,43 Therefore, further studies to
promote effective immune reconstitution in adults should focus on
strategies to enhance T-cell regeneration by thymic independent pathways and peripheral expansion of existing T-cell populations.
| |
ACKNOWLEDGMENT |
The authors gratefully acknowledge the support of Cymbus Biosciences
for generous donation of monoclonal antibodies used in this study. We
also thank Drs S. Allard, D. Bareford, M. Hamilton, S. Jowett, M. Laffan, M. Layton, P. Mahendra, D. Norfolk, D. Swirsky, A. Williams, D. Watson, and J. Yin for providing patient samples and Dr R.A. Jones
(HMDS) for advice on cell culture.
| |
FOOTNOTES |
Submitted January 6, 1999; accepted June 14, 1999.
Supported in part by the Leukaemia Research Fund, UK.
The publication costs of this
article were defrayed in part by
page charge payment. This article
must therefore be hereby marked
"advertisement"
in accordance with 18 U.S.C. section
1734 solely to indicate this fact.
Address reprint requests to Stephen J. Richards, PhD, Haematological
Malignancy Diagnostic Service, The Algernon Firth Building, Leeds
General Infirmary, Leeds, LS1 3EX, UK.
| |
REFERENCES |
1.
Takeda J, Miyata T, Kawagoe K, Iida T, Endo Y, Fujita T, Takahashi M, Kitani T, Kinoshita T:
Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria.
Cell
73:703, 1993[Medline]
[Order article via Infotrieve]
2.
Bessler M, Mason PJ, Hillmen P, Luzzatto L:
Somatic mutations and cellular selection in paroxysmal nocturnal haemoglobinuria.
Lancet
343:951, 1994[Medline]
[Order article via Infotrieve]
3.
Miyata T, Yamada N, Iida Y, Nishimura J, Takeda J, Kitani T, Kinoshita T:
Abnormalities of PIG-A transcripts in granulocytes from patients with paroxysmal nocturnal hemoglobinuria.
N Engl J Med
330:249, 1994[Abstract/Free Full Text]
4.
Bessler M, Mason PJ, Hillmen P, Miyata T, Yamada N, Takeda J, Luzzatto L, Kinoshita T:
Paroxysmal nocturnal haemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene.
EMBO J
13:110, 1994[Medline]
[Order article via Infotrieve]
5.
Ware RE, Rosse WF, Howard TA:
Mutations within the piga gene in patients with paroxysmal nocturnal hemoglobinuria.
Blood
83:2418, 1994[Abstract/Free Full Text]
6.
Bessler M, Mason PJ, Hillmen P, Luzzatto L:
Mutations in the PIG-A gene causing partial deficiency of GPI-linked surface proteins (PNH II) in patients with paroxysmal nocturnal haemoglobinuria.
Br J Haematol
87:863, 1994[Medline]
[Order article via Infotrieve]
7.
Hillmen P, Lewis SM, Bessler M, Luzzatto L, Dacie JV:
Natural history of paroxysmal nocturnal hemoglobinuria.
N Engl J Med
333:1253, 1995[Abstract/Free Full Text]
8.
Ware RE, Hall SE, Rosse WF:
Paroxysmal nocturnal haemoglobinuria with onset in childhood and adolescence.
N Engl J Med
325:991, 1992[Abstract]
9.
Richards SJ, Norfolk DR, Swirsky DM, Hillmen P:
Lymphocyte subset analysis and glycosylphosphatidylinositol phenotype in patients with paroxysmal nocturnal hemoglobinuria.
Blood
92:1799, 1998[Abstract/Free Full Text]
10.
Tseng JE, Hall SE, Howard TA, Ware RE:
Phenotypic and functional analysis of lymphocytes in paroxysmal nocturnal hemoglobinuria.
Am J Hematol
50:244, 1995[Medline]
[Order article via Infotrieve]
11.
Nagakura S, Nakakuma H, Horikawa K, Hidaka M, Kigimoto T, Kawakita M, Tomita M, Takatsuki K:
Expression of decay-accelerating factor and CD59 in lymphocyte subsets of healthy individuals and paroxysmal nocturnal hemoglobinuria patients.
Am J Hematol
43:14, 1993[Medline]
[Order article via Infotrieve]
12.
Schubert J, Uciechowski P, Zielinska-Skowronek M, Tietjen C, Leo R, Schmidt RE:
Differences in activation of normal and glycophosphatidylinositol-negative lymphocytes derived from patients with paroxysmal nocturnal hemoglobinuria.
J Immunol
148:3814, 1992[Abstract]
13.
Presky DH, Low MG, Shevach EM:
Role of phosphatidylinositol-anchored proteins in T cell activation.
J Immunol
144:860, 1990[Abstract]
14.
Korty PE, Brando C, Shevach EM:
CD59 functions as a signal-transducing molecule for human T cell activation.
J Immunol
146:4092, 1991[Abstract]
15.
Iwamoto N, Kawaguchi T, Horikawa K, Nagakura S, Kagimoto T, Suda T, Takatsuki K, Tsuruzaki R:
Preferential hematopoiesis by paroxysmal nocturnal hemoglobinuria clone engrafted in SCID mice.
Blood
87:4944, 1996[Abstract/Free Full Text]
16.
Beverley PCL:
Immunological memory in T cells.
Curr Opin Immunol
3:355, 1991[Medline]
[Order article via Infotrieve]
17.
Akbar AN, Timms A, Janossy G:
Cellular events during memory T cell activation in vitro: The UCHL1 (180 000MW) determinant is newly synthesized after mitosis.
Immunology
66:213, 1989[Medline]
[Order article via Infotrieve]
18.
Akbar AN, Salmon M, Janossy G:
The synergy between naive and memory T cells during activation.
Immunol Today
12:184, 1991[Medline]
[Order article via Infotrieve]
19.
Akbar AN, Terry L, Timms A, Beverley PCL, Janossy G:
Loss of CD45R and gain of UCHL1 positivity is a feature of primed T cells.
J Immunol
140:2171, 1988[Abstract]
20.
Navenot JM, Bernard D, Harousseau JL, Muller JY, Blanchard D:
Expression of glycosyl-phosphatidylinositol-linked glycoproteins in blood cells from paroxysmal nocturnal haemoglobinuria patients. A flow cytometry study using CD55, CD58 and CD59 monoclonal antibodies.
Leuk Lymphoma
21:143, 1996[Medline]
[Order article via Infotrieve]
21.
Kwong YL, Lee CP, Chan TK, Chan LC:
Flow cytometric measurement of glycosylphosphotidyl-inositol-linked surface proteins on blood cells of patients with paroxysmal nocturnal hemoglobinuria.
Am J Clin Pathol
102:30, 1994[Medline]
[Order article via Infotrieve]
22.
Frolova EA, Scott CS, Jones RA:
CD45R0+ T cells immunoregulate spontaneous in vitro immunoglobulin production by normal and chronic lymphocytic leukaemia B-cells.
Leuk Lymphoma
18:103, 1995[Medline]
[Order article via Infotrieve]
23.
Richards SJ, Jones RA, Roberts BE, Patel D, Scott CS:
Relationships between 2H4 (CD45RA) and UCHL1 (CD45RO) expression by normal blood CD4+CD8, CD4CD8+, CD4CD8dim+, CD3+CD4CD8 and CD3CD4CD8 lymphocytes.
Clin Exp Immunol
81:149, 1990[Medline]
[Order article via Infotrieve]
24.
De Jong R, Brouwer M, Miedema F, Van Lier RAW:
Human CD8+ T lymphocytes can be divided in to CD45RA+ and CD45RO+ with different requirements for activation and differentiation.
J Immunol
146:2088, 1991[Abstract]
25.
Leclercq G, Plum J:
Thymic and extrathymic T cell development.
Leukemia
10:1853, 1996[Medline]
[Order article via Infotrieve]
26.
Mackall CL, Hakim FT, Gress RE:
T-cell regeneration: All repertoires are not created equal.
Immunol Today
18:245, 1997[Medline]
[Order article via Infotrieve]
27.
Miller JFAP:
Immunological function of the thymus.
Lancet
2:748, 1961[Medline]
[Order article via Infotrieve]
28.
Spits H, Lanier LL, Phillips JH:
Development of human T and natural killer cells.
Blood
85:2654, 1995[Free Full Text]
29.
Fischer A, Malissen B:
Natural and engineered disorders of lymphocyte development.
Science
280:237, 1998[Abstract/Free Full Text]
30.
Doyle C, Strominger JL:
Interaction between CD4 and class II MHC molecules mediates cell adhesion.
Nature
330:256, 1987[Medline]
[Order article via Infotrieve]
31.
Norment AM, Salter RD, Parham P, Engelhard VH, Littman DR:
Cell-cell adhesion mediated by CD8 and MHC class I molecules.
Nature
336:79, 1988[Medline]
[Order article via Infotrieve]
32.
Mackall CL, Fleisher TA, Brown MR, Andrich MP, Chen CC, Feuerstein IM, Horowitz ME, Magrath IT, Shad AT, Steinberg SM, Wexler LH, Gress RE:
Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy.
N Engl J Med
332:143, 1995[Abstract/Free Full Text]
33.
Heitger A, Neu N, Kern H, Panzer-Grumayer ER, Greinix H, Nachbaur D, Niederwieser D, Fink FM:
Essential role of the thymus to reconstitute naive (CD45RA+) T-Helper cells after human allogeneic bone marrow transplant.
Blood
90:850, 1997[Abstract/Free Full Text]
34.
Mackall CL, Bare CV, Granger LA, Sharrow SO, Titus JA, Gress RE:
Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing.
J Immunol
156:4609, 1996[Abstract]
35.
Mackall CL, Fleisher TA, Brown MR, Andrich MP, Chen CC, Feuerstein IM, Magrath IT, Wexler LH, Dimitrov DS, Gress RE:
Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy.
Blood
89:3700, 1997[Abstract/Free Full Text]
36.
Sprent J, Tough DF:
Lymphocyte life-span and memory.
Science
265:1395, 1994[Abstract/Free Full Text]
37.
Fujii Y, Okumura M, Inada K, Nakahara K:
Reversal of CD45R isoform switching in CD8+ T cells.
Cell Immunol
139:176, 1992[Medline]
[Order article via Infotrieve]
38.
Wills MR, Weekes MP, Mynard K, Carmichael AJ, Sissons JGP:
Following primary HCMV infection pp65-specific CD8+CTL revert from activated CD45RO+ to CD45RA+ memory cells.
Immunology
95:70s-1, 1998 (abstr)
39.
Kondo M, Weissman IL, Akashi K:
Identification of clonogenic common lymphoid progenitors in mouse bone marrow.
Cell
91:661, 1997[Medline]
[Order article via Infotrieve]
40.
Rosti V, Tremml G, Soares V, Pandolfi PP, Luzzatto L, Bessler M:
Murine embryonic stem cells without pig-a gene activity are competent for hematopoiesis with the PNH phenotype but not for clonal expansion.
J Clin Invest
100:1028, 1997[Medline]
[Order article via Infotrieve]
41.
Wise C, Reiser H:
Characterisation of the immunological phenotype of the CD48 knockout mouse: Lymphoid populations, T cell development and humoral immunity.
Immunology
95:78s-1, 1998 (abstr)
42.
Watanabe N, de Rosa SC, Cmelak A, Hoppe R, Herzenberg LA, Herzenberg LA, Roederer M:
Long-term depletion of naive T cells in patients treated for Hodgkin's disease.
Blood
90:3662, 1997[Abstract/Free Full Text]
43.
Hakim FT, Cepeda R, Kaimei S, Mackall CL, McAtee N, Zujewski J, Cowan K, Gress RE:
Constraints on CD4 recovery post-chemotherapy in adults: Thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells.
Blood
90:3789, 1997[Abstract/Free Full Text]
TOP
ABSTRACT
INTRODUCTION
